U.S. Stock News

Ameren recently updated its long-term earnings-per-share guidance, targeting a compound annual growth rate of 6% to 8% from 2025 through 2029, supported by confidence in its regulated utility operations. Analysts highlighted that Ameren’s prospects are being shaped by improved regulation in Missouri, manageable challenges in Illinois, and emerging demand from data centers that could influence future load growth. Now we’ll explore how Ameren’s higher long-term EPS growth guidance could...

Nanjing Leads Biolabs and Dianthus Therapeutics recently reported that the first subject has been dosed in a two-part, placebo-controlled Phase 1 trial of LBL-047 (DNTH212), a bifunctional fusion protein targeting BDCA2 and TACI for potential treatment of systemic lupus erythematosus and other autoimmune diseases. This follows their exclusive global partnership, worth up to US$1.00 billion, under which Dianthus holds rights to develop and commercialize DNTH212 outside Greater China,...

Keurig Dr Pepper (KDP) is back on investor radars after recent share moves, with the stock closing at US$27.32. That puts fresh attention on its earnings profile and longer term return record. See our latest analysis for Keurig Dr Pepper. Recent trading has been soft, with a 1 month share price return of a 4.78% decline and a year to date share price return of a 1.48% decline. The 1 year total shareholder return of an 8.15% decline points to fading momentum, despite a 90 day share price...

Investor interest in Ondas Holdings (ONDS) has picked up after the company moved its headquarters to West Palm Beach, Florida, and announced fresh autonomous systems orders tied to defense and security customers. See our latest analysis for Ondas Holdings. Those headlines around the headquarters move, name change to Ondas Inc., new autonomous systems orders and the upcoming Investor Day have landed alongside sharp price moves, with a 39.38% 7 day share price return and a very large 1 year...

In recent weeks, AppLovin has intensified its focus on AI-driven advertising by divesting its mobile gaming unit for US$900 million and pushing deeper into sectors such as e-commerce, fintech, and automotive ads, while also facing ongoing SEC scrutiny over data-collection practices. This combination of a sharper ad-tech focus, robust reported fundamentals, and heightened regulatory and valuation concerns is prompting investors to reassess how AppLovin’s business mix and risk profile align...

Legal dispute over noncompete policy and why it matters for Boston Beer Company stock Boston Beer Company (SAM) is now at the center of a lawsuit challenging its noncompete policy under Massachusetts law, raising questions around how any outcome could influence its employment practices and investor sentiment. See our latest analysis for Boston Beer Company. At a share price of $197.87, Boston Beer has seen a 1-day share price return decline of about 1% and a 90-day share price return decline...

In recent weeks, Colgate-Palmolive has drawn fresh attention as a Dividend King, with analysts highlighting its science-based innovation, cost initiatives, and focus on higher-growth oral and home care categories ahead of its upcoming fourth-quarter earnings release. This renewed focus on the company’s dividend track record, margin resilience, and execution in emerging markets is reinforcing its reputation as a defensive consumer staples leader. We’ll now examine how Colgate-Palmolive’s...

Why Icahn Enterprises is back on investors’ radar Icahn Enterprises (IEP) has drawn fresh attention after recent trading left the units around $7.77, prompting investors to reassess its diversified operations, distribution profile and the partnership’s mixed return record over recent years. See our latest analysis for Icahn Enterprises. Recent trading has been choppy, with a 1 day share price return of 3.88% and a 7 day share price return of 6.44% contrasting with weaker 90 day share price...

What F.N.B’s Recent Performance Tells Investors F.N.B (FNB) has drawn fresh attention after a steady pattern of returns, including about 1.2% over the past day, 2.8% over the past month, and 7.7% over the past 3 months. For investors tracking bank stocks, those figures sit alongside a year total return of 22.2% and multi year returns of 45.3% over 3 years and 90.0% over 5 years, based on current data. That share performance is supported by reported annual revenue of US$1.59b and net income of...

Recently, U.S. forces carried out strikes in Venezuela, including a large-scale raid involving more than 150 aircraft such as F-35 and F-22 jets, bringing defense contractors like Lockheed Martin into sharp focus amid heightened geopolitical tensions. At the same time, Lockheed Martin’s record-high backlog, major new contracts, and ongoing margin pressures from fixed-price programs are drawing attention to whether stronger demand can translate into sustainably higher profitability. We’ll now...

Why Rexford Industrial Realty Is On Investors’ Screens Today Rexford Industrial Realty (REXR) is in focus after recent trading left the stock at a last close of $39.02, with investors weighing its current valuation, returns profile, and underlying operating metrics. See our latest analysis for Rexford Industrial Realty. Recent trading has been relatively soft, with a 30-day share price return of 4.20% and a year to date share price return of 0.03%. The 1-year total shareholder return of 5.99%...

Trinity Industries, Inc. ( NYSE:TRN ) has announced that it will be increasing its dividend from last year's comparable...

The White House recently delayed planned tariff hikes on a range of imported home goods, including furniture and cabinets, for one year. This pause eases near-term cost pressure for retailers such as Academy Sports and Outdoors that source merchandise tied to home and lifestyle categories. We’ll now examine how this temporary tariff relief could influence Academy Sports and Outdoors’ investment narrative and its cost structure focus. Find companies with promising cash flow potential yet...

In the past few days, Laureate Education reported an 8.6% year-on-year revenue increase that exceeded analyst expectations by 3.7%, supported by strong fully online offerings in Peru and continued expansion in Mexico despite a softer macro backdrop. This performance prompted Laureate to raise its full-year 2025 outlook, signaling management’s increased confidence in the company’s trajectory amid favorable currency trends. We’ll now explore how the raised 2025 outlook, driven by online...

Franklin Templeton recently highlighted what it views as compelling opportunities across private markets, emphasizing private equity secondaries, commercial real estate debt, real estate, and infrastructure, while expanding its global reach and product lineup to meet growing demand for these solutions. An important insight is the firm’s focus on infrastructure themes such as digital networks, decarbonization, deglobalization, and demographics, which signals a targeted approach to building...

Apogee Therapeutics recently reported positive interim Phase 1b data for its half-life extended anti-IL-13 antibody zumilokibart (APG777) in adults with mild-to-moderate asthma, showing favorable safety and robust, durable FeNO suppression after a single 720 mg dose. The company also outlined an ambitious 2026 clinical roadmap, including multiple atopic dermatitis readouts, expansion into additional inflammatory and immunology indications, and a Phase 3 start that could position zumilokibart...

In early 2026, CVR Partners, LP outlined preliminary 2026 capital spending of US$60,000,000 to US$75,000,000 for ammonia expansion, feedstock diversification at Coffeyville, water quality upgrades at both plants, and increased diesel exhaust fluid production and loadout capacity. An interesting angle is that management is explicitly targeting utilization rates above 95 percent of nameplate capacity, underscoring a focus on squeezing more output from existing assets rather than adding...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are...

Biogen and Eisai previously announced that China’s National Medical Products Administration accepted their Biologics License Application for a subcutaneous, once-weekly at-home formulation of Alzheimer’s therapy LEQEMBI, advancing it into formal regulatory review. This move could materially change how Alzheimer’s care is delivered in China by shifting treatment from hospital-based infusions to more convenient at-home self-administration. Next, we’ll explore how the potential for at-home...

It's not a stretch to say that Titan America SA's ( NYSE:TTAM ) price-to-earnings (or "P/E") ratio of 18.5x right now...

Why WaFd is on investors’ radar WaFd (WAFD) has drawn attention after recent share price moves, with the stock closing at $32.47. That invites a closer look at how its returns and fundamentals line up today. See our latest analysis for WaFd. WaFd’s recent 1 day share price return of 1.06% comes after a steadier patch, with a 90 day share price return of 11.35% and a 5 year total shareholder return of 33.43%. This points to momentum building over a longer stretch rather than just a short term...

With no single headline event driving attention, Essential Utilities (WTRG) has come into focus as investors reassess regulated water and natural gas utilities, looking at recent returns, current valuation signals, and its latest financial profile. See our latest analysis for Essential Utilities. At a share price of US$37.79, Essential Utilities has seen pressure in recent months, with a 90 day share price return showing a decline of 7.92%. By contrast, the 1 year total shareholder return of...

In late 2025, Birchtech Corp. reported a final court opinion in its long-running patent lawsuits over clean air technologies, confirming an expected US$78 million judgment plus accruing interest and highlighting earlier pre-trial settlements reached in 2023 with several defendants, including DTE Energy. By resolving these patent disputes and securing licensing arrangements, Birchtech aims to reinvest proceeds into water purification technologies, while utilities such as DTE Energy continue...